title: A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma.
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Ajai
authors.initials: A
authors.lastname: Chari
authors.affiliation: NYU Langone Medical Center, New York, NY, USA.
authors.forename: Amitabha
authors.initials: A
authors.lastname: Mazumder
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Lau
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Donna
authors.initials: D
authors.lastname: Catamero
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Zachary
authors.initials: Z
authors.lastname: Galitzeck
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Sundar
authors.initials: S
authors.lastname: Jagannath
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use*; D058070:Asymptomatic Diseases; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D010936:Plant Extracts / Q000627:therapeutic use*; D012616:Sea Cucumbers / Q000737:chemistry*; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts
keywords: cancer; myeloma; myeloma therapy; risk factors